• 4720 Citations
  • 36 Scopus h-Index
19982020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

2020

Association between High-Grade Myelodysplastic Syndrome and Cutaneous Langerhans Cell Histiocytosis Suggested by Next-Generation Sequencing

Khurana, S., Sluzevich, J. C., He, R., Reimer, D. K., Kharfan-Dabaja, M. A., Foran, J. M. & Jiang, L., 2020, (Accepted/In press) In : JAMA Dermatology.

Research output: Contribution to journalLetter

Clinical utility of fluorescence in situ hybridization-based diagnosis of BCR-ABL1 like (Philadelphia chromosome like) B-acute lymphoblastic leukemia

Anagnostou, T., Knudson, R. A., Pearce, K. E., Meyer, R. G., Pitel, B. A., Peterson, J. F., Baughn, L. B., Reichard, K. K., Ketterling, R. P., Kloft-Nelson, S. M., Knutson, D. L., Khan, S. P., Gangat, N., Litzow, M. R., Hogan, W. J., Wolanskyj, A., Al-Kali, A., Begna, K. H., Elliott, M., Pardanani, A. & 8 others, Foran, J., Shah, M., Tefferi, A., Alkhateeb, H., Halling, K. C., Rodriguez, V., Greipp, P. T. & Patnaik, M. M., Mar 1 2020, In : American journal of hematology. 95, 3, p. E68-E72

Research output: Contribution to journalLetter

Open Access

Hairy cell leukemia with CCND1/IGH fusion gene and BRAF V600E mutation

Rahman, Z. A., Muwalla, F., Jiang, L. & Foran, J., 2020, In : Leukemia Research Reports. 13, 100197.

Research output: Contribution to journalArticle

Open Access

Molecular and phenotypic characterization of an early T-cell precursor acute lymphoblastic lymphoma harboring PICALM-MLLT10 fusion with aberrant expression of B-cell antigens

Khurana, S., Melody, M. E., Ketterling, R. P., Peterson, J. F., Luoma, I. M., Vazmatzis, G., Tun, H. W., Foran, J. M. & Jiang, L., Jan 2020, In : Cancer Genetics. 240, p. 40-44 5 p.

Research output: Contribution to journalArticle

2019

Acute myeloid leukemia, version 3.2019

Tallman, M. S., Wang, E. S., Altman, J. K., Appelbaum, F. R., Bhatt, V. R., Bixby, D., Coutre, S. E., De Lima, M., Fathi, A. T., Fiorella, M., Foran, J. M., Hall, A. C., Jacoby, M., Lancet, J., LeBlanc, T. W., Mannis, G., Marcucci, G., Martin, M. G., Mims, A., O'Donnell, M. R. & 14 others, Olin, R., Peker, D., Perl, A., Pollyea, D. A., Pratz, K., Prebet, T., Ravandi, F., Shami, P. J., Stone, R. M., Strickland, S. A., Wieduwilt, M., Gregory, K. M., Hammond, L. & Ogba, N., Jan 1 2019, In : JNCCN Journal of the National Comprehensive Cancer Network. 17, 6, p. 721-749 29 p.

Research output: Contribution to journalArticle

Open Access
41 Scopus citations

Allogeneic hematopoietic cell transplantation compared to chemotherapy consolidation in older acute myeloid leukemia (AML) patients 60–75 years in first complete remission (CR1): an alliance (A151509), SWOG, ECOG-ACRIN, and CIBMTR study

Ustun, C., Le-Rademacher, J., Wang, H. L., Othus, M., Sun, Z., Major, B., Zhang, M. J., Storrick, E., Lafky, J. M., Chow, S., Mrózek, K., Attar, E. C., Nand, S., Bloomfield, C. D., Cripe, L. D., Tallman, M. S., Appelbaum, F., Larson, R. A., Marcucci, G., Roboz, G. J. & 12 others, Uy, G. L., Stone, R. M., Jatoi, A., Shea, T. C., de Lima, M., Foran, J. M., Sandmaier, B. M., Litzow, M. R., Erba, H. P., Hurria, A., Weisdorf, D. J. & Artz, A. S., Nov 1 2019, In : Leukemia. 33, 11, p. 2599-2609 11 p.

Research output: Contribution to journalArticle

Open Access
9 Scopus citations

Efficacy of Allogeneic Hematopoietic Cell Transplantation in Cutaneous T Cell Lymphoma: Results of a Systematic Review and Meta-Analysis

Iqbal, M., Reljic, T., Ayala, E., Sher, T., Murthy, H., Roy, V., Foran, J., Tun, H., Kumar, A. & Kharfan-Dabaja, M. A., Jan 1 2019, (Accepted/In press) In : Biology of Blood and Marrow Transplantation.

Research output: Contribution to journalArticle

1 Scopus citations

Elderly acute lymphoblastic leukemia: a Mayo Clinic study of 124 patients

Miller, K. C., Al-Kali, A., Shah, M. V., Hogan, W. J., Elliott, M. A., Begna, K. H., Gangat, N., Patnaik, M. M., Viswanatha, D. S., He, R., Greipp, P. T., Sproat, L. Z., Foran, J. M., Litzow, M. R. & Alkhateeb, H. B., Mar 21 2019, In : Leukemia and Lymphoma. 60, 4, p. 990-999 10 p.

Research output: Contribution to journalArticle

3 Scopus citations

Impact of hospital hospitality house programs on quality of life and mood of patients and caregivers after hematopoietic stem cell transplant

Torres, M. E., Hashmi, S. K., Stevens, M. A., Tan, A. D., Callahan, V., Sloan, J. A., Hogan, W. J., Litzow, M. R., Roy, V., Foran, J. M. & Colon-Otero, G., Sep 2019, In : Hematology/ Oncology and Stem Cell Therapy. 12, 3, p. 155-160 6 p.

Research output: Contribution to journalArticle

Outcome of Myelodysplastic Syndromes Over Time in the United States: A National Cancer Data Base Study From 2004-2013

Al-Kali, A., Zblewski, D., Foran, J. M., Patnaik, M. M., Larrabee, B. R., Gangat, N., Begna, K., Elliott, M. A., Hogan, W., Tefferi, A., Litzow, M. R. & Go, R. S., Aug 1 2019, In : Mayo Clinic proceedings. 94, 8, p. 1467-1474 8 p.

Research output: Contribution to journalArticle

2 Scopus citations

The National MDS Natural History Study: design of an integrated data and sample biorepository to promote research studies in myelodysplastic syndromes

Sekeres, M. A., Gore, S. D., Stablein, D. M., DiFronzo, N., Abel, G. A., DeZern, A. E., Troy, J. D., Rollison, D. E., Thomas, J. W., Waclawiw, M. A., Liu, J. J., Al Baghdadi, T., Walter, M. J., Bejar, R., Gorak, E. J., Starczynowski, D. T., Foran, J. M., Cerhan, J. R., Moscinski, L. C., Komrokji, R. S. & 2 others, Deeg, H. J. & Epling-Burnette, P. K., Jan 1 2019, In : Leukemia and Lymphoma.

Research output: Contribution to journalArticle

3 Scopus citations

Two-dimensional speckle-tracking strain detects subclinical cardiotoxicity in older patients treated for acute myeloid leukemia

Cascino, G. J., Voss, W. B., Canaani, J., Furiasse, N., Rademaker, A., Ky, B., Luger, S., Altman, J. K., Foran, J. M., Litzow, M. R., Tallman, M. S., Rigolin, V. & Akhter, N., Nov 1 2019, In : Echocardiography. 36, 11, p. 2033-2040 8 p.

Research output: Contribution to journalArticle

2018

Durable remissions with ivosidenib in IDH1-mutated relapsed or refractory AML

DiNardo, C. D., Stein, E. M., De Botton, S., Roboz, G. J., Altman, J. K., Mims, A. S., Swords, R., Collins, R. H., Mannis, G. N., Pollyea, D. A., Donnellan, W., Fathi, A. T., Pigneux, A., Erba, H. P., Prince, G. T., Stein, A. S., Uy, G. L., Foran, J. M., Traer, E., Stuart, R. K. & 20 others, Arellano, M. L., Slack, J. L., Sekeres, M. A., Willekens, C., Choe, S., Wang, H., Zhang, V., Yen, K. E., Kapsalis, S. M., Yang, H., Dai, D., Fan, B., Goldwasser, M., Liu, H., Agresta, S., Wu, B., Attar, E. C., Tallman, M. S., Stone, R. M. & Kantarjian, H. M., Jun 21 2018, In : New England Journal of Medicine. 378, 25, p. 2386-2398 13 p.

Research output: Contribution to journalArticle

282 Scopus citations

Lenalidomide plus R-CHOP21 in newly diagnosed diffuse large B-cell lymphoma (DLBCL): long-term follow-up results from a combined analysis from two phase 2 trials

Castellino, A., Chiappella, A., LaPlant, B. R., Pederson, L. D., Gaidano, G., Macon, W. R., Inghirami, G., Reeder, C. B., Tucci, A., King, R. L., Congiu, A., Foran, J. M., Pavone, V., Rivera, C. E., Spina, M., Ansell, S. M., Cavallo, F., Molinari, A. L., Ciccone, G., Habermann, T. M. & 3 others, Witzig, T. E., Vitolo, U. & Nowakowski, G. S., Nov 1 2018, In : Blood cancer journal. 8, 11, 108.

Research output: Contribution to journalArticle

8 Scopus citations

Myelodysplasia-related acute myeloid leukemia and acute promyelocytic leukemia: Concomitant occurrence of two molecularly distinct diseases

Vanegas, Y. A. M., Azzouqa, A. G. M., Menke, D. M., Foran, J. M. & Vishnu, P., Sep 5 2018, In : Hematology Reports. 10, 3, p. 59-61 3 p., 7658.

Research output: Contribution to journalArticle

1 Scopus citations

Non-internal tandem duplication (ITD), non-tyrosine kinase domain (TKD) FLT3 mutations in myeloid malignancies: A brief report of 10 patients

Higgins, A., Mangaonkar, A. A., Torghabeh, M. H., Gangat, N., Viswanatha, D., Horna, P. & Foran, J. M., Sep 1 2018, In : Leukemia Research. 72, p. 1-4 4 p.

Research output: Contribution to journalLetter

Pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, combined with azacitidine in patients with AML

Swords, R. T., Coutre, S., Maris, M. B., Zeidner, J. F., Foran, J. M., Cruz, J., Erba, H. P., Berdeja, J. G., Tam, W., Vardhanabhuti, S., Pawlikowska-Dobler, I., Faessel, H. M., Dash, A. B., Sedarati, F., Dezube, B. J., Faller, D. V. & Savona, M. R., Mar 29 2018, In : Blood. 131, 13, p. 1415-1424 10 p.

Research output: Contribution to journalArticle

58 Scopus citations

Phase 1 study of quizartinib in combination with induction and consolidation chemotherapy in patients with newly diagnosed acute myeloid leukemia

Altman, J. K., Foran, J. M., Pratz, K. W., Trone, D., Cortes, J. E. & Tallman, M. S., Feb 1 2018, In : American journal of hematology. 93, 2, p. 213-221 9 p.

Research output: Contribution to journalArticle

35 Scopus citations
2017

Acute myeloid leukemia, version 3.2017: Clinical practice guidelines in oncology

O'Donnell, M. R., Tallman, M. S., Abboud, C. N., Altman, J. K., Appelbaum, F. R., Arber, D. A., Bhatt, V., Bixby, D., Blum, W., Coutre, S. E., De Lima, M., Fathi, A. T., Fiorella, M., Foran, J. M., Gore, S. D., Hall, A. C., Kropf, P., Lancet, J., Maness, L. J., Marcucci, G. & 14 others, Martin, M. G., Moore, J. O., Olin, R., Peker, D., Pollyea, D. A., Pratz, K., Ravandi, F., Shami, P. J., Stone, R. M., Strickland, S. A., Wang, E. S., Wieduwilt, M., Gregory, K. & Ogba, N., Jul 1 2017, In : JNCCN Journal of the National Comprehensive Cancer Network. 15, 7, p. 926-957 32 p.

Research output: Contribution to journalReview article

170 Scopus citations

Assessment of drug sensitivity in hematopoietic stem and progenitor cells from acute myelogenous leukemia and myelodysplastic syndrome ex vivo

Knorr, K. L. B., Finn, L. E., Douglas Smith, B., Hess, A. D., Foran, J. M., Karp, J. E. & Kaufmann, S. H., Mar 1 2017, In : Stem cells translational medicine. 6, 3, p. 840-850 11 p.

Research output: Contribution to journalArticle

3 Scopus citations

Association of Therapy for Autoimmune Disease With Myelodysplastic Syndromes and Acute Myeloid Leukemia

Ertz-Archambault, N., Kosiorek, H., Taylor, G. E., Kelemen, K., Dueck, A., Castro, J., Marino, R., Gauthier, S., Finn, L. E., Sproat, L. Z., Palmer, J., Mesa, R. A., Al-Kali, A., Foran, J. & Tibes, R., Jul 1 2017, In : JAMA oncology. 3, 7, p. 936-943 8 p.

Research output: Contribution to journalArticle

31 Scopus citations

Current treatment preferences in chronic myeloid leukemia: The Mayo Clinic Physicians' survey

Begna, K., Al-Kali, A., Elliott, M., Foran, J., Gangat, N., Hogan, W., Hook, C., Leis, J., Litzow, M., Mesa, R., Palmer, J., Pardanani, A., Patnaik, M., Rivera, C., Sproat, L., Tibes, R., Wolanskyj-Spinner, A. & Tefferi, A., 2017, (Accepted/In press) In : American Journal of Hematology.

Research output: Contribution to journalArticle

1 Scopus citations
2 Scopus citations

Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States

Muffly, L., Pasquini, M. C., Martens, M., Brazauskas, R., Zhu, X., Adekola, K., Aljurf, M., Ballen, K. K., Bajel, A., Baron, F., Battiwalla, M., Beitinjaneh, A., Cahn, J. Y., Carabasi, M., Chen, Y. B., Chhabra, S., Ciurea, S., Copelan, E., D’Souza, A., Edwards, J. & 31 others, Foran, J., Freytes, C. O., Fung, H. C., Gale, R. P., Giralt, S., Hashmi, S. K., Hildebrandt, G. C., Ho, V., Jakubowski, A., Lazarus, H., Luskin, M. R., Martino, R., Maziarz, R., McCarthy, P., Nishihori, T., Olin, R., Olsson, R. F., Pawarode, A., Peres, E., Rezvani, A. R., Rizzieri, D., Savani, B. N., Schouten, H. C., Sabloff, M., Seftel, M., Seo, S., Sorror, M. L., Szer, J., Wirk, B. M., Wood, W. A. & Artz, A., Aug 31 2017, In : Blood. 130, 9, p. 1156-1164 9 p.

Research output: Contribution to journalArticle

79 Scopus citations

Intergroup LEAP trial (S1612): A randomized phase 2/3 platform trial to test novel therapeutics in medically less fit older adults with acute myeloid leukemia

Walter, R. B., Michaelis, L. C., Othus, M., Uy, G. L., Radich, J. P., Little, R. F., Hita, S., Saini, L., Foran, J. M., Gerds, A. T., Klepin, H. D., Hay, A. E., Assouline, S., Lancet, J. E., Couban, S., Litzow, M. R., Stone, R. M. & Erba, H. P., Jan 1 2017, (Accepted/In press) In : American Journal of Hematology.

Research output: Contribution to journalArticle

5 Scopus citations

Older patients with acute myeloid leukemia: Treatment challenges and future directions

Finn, L., Dalovisio, A. & Foran, J. M., Dec 1 2017, In : Ochsner Journal. 17, 4, p. 398-404 7 p.

Research output: Contribution to journalReview article

11 Scopus citations

Prevalence of BCL-2/J(H) Translocation in Healthy African Americans

Colon-Otero, G., Van Wier, S. A., Ahmann, G. J., Braggio, E. D., Albertie, M. L., Weis, J. A., Ailawadhi, S., Cerhan, J. R., Vishnu, P., Jorgensen, M. S., Foran, J. M., Thomas, C. S. & Fonseca, R., Jan 1 2017, In : Annals of Hematology. 96, 1, p. 51-55 5 p.

Research output: Contribution to journalArticle

Second primary acute lymphoblastic leukemia in adults: A SEER analysis of incidence and outcomes

Swaika, A., Frank, R. D., Yang, D., Finn, L. E., Jiang, L., Advani, P., Chanan-Khan, A. A., Ailawadhi, S. & Foran, J. M., Jan 1 2017, (Accepted/In press) In : Cancer Medicine.

Research output: Contribution to journalArticle

14 Scopus citations
2016

Activity of the oral mitogen-activated protein kinase kinase inhibitor trametinib in RAS-mutant relapsed or refractory myeloid malignancies

Borthakur, G., Popplewell, L., Boyiadzis, M., Foran, J. M., Platzbecker, U., Vey, N., Walter, R. B., Olin, R., Raza, A., Giagounidis, A., Al-Kali, A., Jabbour, E., Kadia, T., Garcia-Manero, G., Bauman, J. W., Wu, Y., Liu, Y., Schramek, D., Cox, D. S., Wissel, P. & 1 others, Kantarjian, H., 2016, (Accepted/In press) In : Cancer.

Research output: Contribution to journalArticle

51 Scopus citations

Are we curing more older adults with acute myeloid leukemia with allogeneic transplantation in CR1?

Finn, L. E. & Foran, J. M., Mar 1 2016, In : Current opinion in hematology. 23, 2, p. 95-101 7 p.

Research output: Contribution to journalReview article

1 Scopus citations

Impact of access to NCI- and NCCN-designated cancer centers on outcomes for multiple myeloma patients: A SEER registry analysis

Ailawadhi, S., Advani, P., Yang, D., Ghosh, R., Swaika, A., Roy, V., Foran, J. M., Colon-Otero, G. & Chanan Khan, A. A., Feb 15 2016, In : Cancer. 122, 4, p. 618-625 8 p.

Research output: Contribution to journalArticle

10 Scopus citations

Phase I study of single-agent CC-292, a highly selective bruton’s tyrosine kinase inhibitor, in relapsed/refractory chronic lymphocytic leukemia

Brown, J. R., Harb, W. A., Hill, B. T., Gabrilove, J., Sharman, J. P., Schreeder, M. T., Barr, P. M., Foran, J. M., Miller, T. P., Burger, J. A., Kelly, K. R., Mahadevan, D., Ma, S., Li, Y., Pierce, D. W., Barnett, E., Marine, J., Miranda, M., Azaryan, A., Yu, X. & 3 others, Nava-Parada, P., Mei, J. & Kipps, T. J., Jan 1 2016, In : Haematologica. 101, 7, p. e295-e298

Research output: Contribution to journalLetter

26 Scopus citations
2015

Disseminated extranodal marginal zone lymphoma involving the gastrocnemius muscle with sural neurolymphomatosis

Advani, P., Jiang, L., Srinivasan, S. & Foran, J. M., Nov 22 2015, In : Annals of Hematology. 94, 11, p. 1939-1940 2 p.

Research output: Contribution to journalArticle

2 Scopus citations

Epidemiology of adult acute myeloid leukemia: Impact of exposures on clinical phenotypes and outcomes after therapy

Finn, L., Sproat, L., Heckman, M. G., Jiang, L., Diehl, N. N., Ketterling, R., Tibes, R., Valdez, R. & Foran, J. M., Dec 1 2015, In : Cancer Epidemiology. 39, 6, p. 1084-1092 9 p.

Research output: Contribution to journalArticle

16 Scopus citations

Health insurance-related disparities in lymphoma survival are partly mediated by baseline clinical factors

Olszewski, A. J. & Foran, J. M., Sep 1 2015, In : Oncologist. 20, 10, p. 1223-1224 2 p.

Research output: Contribution to journalLetter

2 Scopus citations

In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs

Tefferi, A., Kantarjian, H., Rajkumar, S. V., Baker, L. H., Abkowitz, J. L., Adamson, J. W., Advani, R. H., Allison, J., Antman, K. H., Bast, R. C., Bennett, J. M., Benz, E. J., Berliner, N., Bertino, J., Bhatia, R., Bhatia, S., Bhojwani, D., Blanke, C. D., Bloomfield, C. D., Bosserman, L. & 95 others, Broxmeyer, H. E., Byrd, J. C., Cabanillas, F., Canellos, G. P., Chabner, B. A., Chanan-Khan, A., Cheson, B., Clarkson, B., Cohn, S. L., Colon-Otero, G., Cortes, J., Coutre, S., Cristofanilli, M., Curran, W. J., Daley, G. Q., Deangelo, D. J., Deeg, H. J., Einhorn, L. H., Erba, H. P., Esteva, F. J., Estey, E., Fidler, I. J., Foran, J., Forman, S., Freireich, E., Fuchs, C., George, J. N., Gertz, M. A., Giralt, S., Golomb, H., Greenberg, P., Gutterman, J., Handin, R. I., Hellman, S., Hoff, P. M., Hoffman, R., Hong, W. K., Horowitz, M., Hortobagyi, G. N., Hudis, C., Issa, J. P., Johnson, B. E., Kantoff, P. W., Kaushansky, K., Khayat, D., Khuri, F. R., Kipps, T. J., Kripke, M., Kyle, R. A., Larson, R. A., Lawrence, T. S., Levine, R., Link, M. P., Lippman, S. M., Lonial, S., Lyman, G. H., Markman, M., Mendelsohn, J., Meropol, N. J., Messinger, Y., Mulvey, T. M., O'Brien, S., Perez-Soler, R., Pollock, R., Prchal, J., Press, O., Radich, J., Rai, K., Rosenberg, S. A., Rowe, J. M., Rugo, H., Runowicz, C. D., Sandmaier, B. M., Saven, A., Schafer, A. I., Schiffer, C., Sekeres, M. A., Silver, R. T., Siu, L. L., Steensma, D. P., Stewart, F. M., Stock, W., Stone, R., Storb, R., Strong, L. C., Tallman, M. S., Thompson, M., Ueno, N. T., Van Etten, R. A., Vose, J. M., Wiernik, P. H., Winer, E. P., Younes, A., Zelenetz, A. D. & Lemaistre, C. A., Aug 1 2015, In : Mayo Clinic proceedings. 90, 8, p. 996-1000 5 p.

Research output: Contribution to journalShort survey

104 Scopus citations
213 Scopus citations
12 Scopus citations

The Hedgehog pathway as targetable vulnerability with 5-azacytidine in myelodysplastic syndrome and acute myeloid leukemia

Tibes, R., Al-Kali, A., Oliver, G. R., Delman, D. H., Hansen, N., Bhagavatula, K., Mohan, J., Rakhshan, F., Wood, T., Foran, J. M., Mesa, R. A. & Bogenberger, J. M., Oct 20 2015, (Accepted/In press) In : Journal of Hematology and Oncology.

Research output: Contribution to journalArticle

28 Scopus citations
2014

A phase i and pharmacodynamic study of AT9283, a small-molecule inhibitor of aurora kinases in patients with relapsed/refractory leukemia or myelofibrosis

Foran, J., Ravandi, F., Wierda, W., Garcia-Manero, G., Verstovsek, S., Kadia, T., Burger, J., Yule, M., Langford, G., Lyons, J., Ayrton, J., Lock, V., Borthakur, G., Cortes, J. & Kantarjian, H., Jun 2014, In : Clinical Lymphoma, Myeloma and Leukemia. 14, 3, p. 223-230 8 p.

Research output: Contribution to journalArticle

21 Scopus citations

A Rare Case of Primary High-Grade Large B-Cell Lymphoma of the Sciatic Nerve

Advani, P., Paulus, A., Murray, P., Jiang, L., Goff, R., Pooley, R., Jain, M., Garner, H. & Foran, J. M., Sep 18 2014, (Accepted/In press) In : Clinical Lymphoma, Myeloma and Leukemia.

Research output: Contribution to journalArticle

5 Scopus citations

AT-101 downregulates BCL2 and MCL1 and potentiates the cytotoxic effects of lenalidomide and dexamethasone in preclinical models of multiple myeloma and Waldenström macroglobulinaemia

Paulus, A., Chitta, K., Akhtar, S., Personett, D., Miller, K. C., Thompson, K. J., Carr, J., Kumar, S., Roy, V., Ansell, S. M., Mikhael, J. R., Dispenzieri, A., Reeder, C. B., Rivera, C. E., Foran, J. & Chanan-Khan, A., Feb 1 2014, In : British journal of haematology. 164, 3, p. 352-365 14 p.

Research output: Contribution to journalArticle

19 Scopus citations

Etiologic heterogeneity among non-hodgkin lymphoma subtypes: The interLymph non-hodgkin lymphoma subtypes project

Morton, L. M., Slager, S. L., Cerhan, J. R., Wang, S. S., Vajdic, C. M., Skibola, C. F., Bracci, P. M., de Sanjosé, S., Smedby, K. E., Chiu, B. C. H., Zhang, Y., Mbulaiteye, S. M., Monnereau, A., Turner, J. J., Clavel, J., Adami, H. O., Chang, E. T., Glimelius, B., Hjalgrim, H., Melbye, M. & 67 others, Crosignani, P., di Lollo, S., Miligi, L., Nanni, O., Ramazzotti, V., Rodella, S., Costantini, A. S., Stagnaro, E., Tumino, R., Vindigni, C., Vineis, P., Becker, N., Benavente, Y., Boffetta, P., Brennan, P., Cocco, P., Foretova, L., Maynadié, M., Nieters, A., Staines, A., Colt, J. S., Cozen, W., Davis, S., de Roos, A. J., Hartge, P., Rothman, N., Severson, R. K., Holly, E. A., Call, T. G., Feldman, A. L., Habermann, T. M., Liebow, M., Blair, A., Cantor, K. P., Kane, E. V., Lightfoot, T., Roman, E., Smith, A., Brooks-Wilson, A., Connors, J. M., Gascoyne, R. D., Spinelli, J. J., Armstrong, B. K., Kricker, A., Holford, T. R., Lan, Q., Zheng, T., Orsi, L., Dal Maso, L., Franceschi, S., La Vecchia, C., Negri, E., Serraino, D., Bernstein, L., Levine, A., Friedberg, J. W., Kelly, J. L., Berndt, S. I., Birmann, B. M., Clarke, C. A., Flowers, C. R., Foran, J. M., Kadin, M. E., Paltiel, O., Weisenburger, D. D., Linet, M. S. & Sampson, J. N., Aug 2014, In : Journal of the National Cancer Institute - Monographs. 48, p. 130-144 15 p.

Research output: Contribution to journalArticle

160 Scopus citations

Frontline therapy of AML: Should the older patient be treated differently?

Foran, J. M., Jun 2014, In : Current Hematologic Malignancy Reports. 9, 2, p. 100-108 9 p.

Research output: Contribution to journalReview article

6 Scopus citations

Medical history, lifestyle, family history, and occupational risk factors for Diffuse Large B-cell Lymphoma: The interLymph non-Hodgkin lymphoma subtypes project

Cerhan, J. R., Kricker, A., Paltiel, O., Flowers, C. R., Wang, S. S., Monnereau, A., Blair, A., Maso, L. D., Kane, E. V., Nieters, A., Foran, J. M., Miligi, L., Clavel, J., Bernstein, L., Rothman, N., Slager, S. L., Sampson, J. N., Morton, L. M. & Skibola, C. F., Aug 2014, In : Journal of the National Cancer Institute - Monographs. 48, p. 15-25 11 p.

Research output: Contribution to journalArticle

59 Scopus citations

Socioeconomic disparities in mortality after diffuse large B-cell lymphoma in the modern treatment era

Tao, L., Foran, J. M., Clarke, C. A., Gomez, S. L. & Keegan, T. H. M., Jun 5 2014, In : Blood. 123, 23, p. 3553-3562 10 p.

Research output: Contribution to journalArticle

43 Scopus citations

The investigational agent MLN2238 induces apoptosis and is cytotoxic to CLL cells in vitro, as a single agent and in combination with other drugs

Paulus, A., Masood, A., Miller, K. C., Nazmul, A. N. M., Akhtar, D., Advani, P., Foran, J., Rivera, C., Roy, V., Colon-Otero, G., Chitta, K. & Chanan-Khan, A., Apr 2014, In : British journal of haematology. 165, 1, p. 78-88 11 p.

Research output: Contribution to journalArticle

6 Scopus citations
2013

Examining racial differences in diffuse large B-cell lymphoma presentation and survival

Flowers, C. R., Shenoy, P. J., Borate, U., Bumpers, K., Douglas-Holland, T., King, N., Brawley, O. W., Lipscomb, J., Lechowicz, M. J., Sinha, R., Grover, R. S., Bernal-Mizrachi, L., Kowalski, J., Donnellan, W., The, A., Reddy, V., Jaye, D. L. & Foran, J., Feb 1 2013, In : Leukemia and Lymphoma. 54, 2, p. 268-276 9 p.

Research output: Contribution to journalArticle

29 Scopus citations

Phase I study of quizartinib administered daily to patients with relapsed or refractory acute myeloid leukemia irrespective of FMS-like tyrosine kinase 3-internal tandem duplication status

Cortes, J. E., Kantarjian, H., Foran, J. M., Ghirdaladze, D., Zodelava, M., Borthakur, G., Gammon, G., Trone, D., Armstrong, R. C., James, J. & Levis, M., Oct 10 2013, In : Journal of Clinical Oncology. 31, 29, p. 3681-3867 187 p.

Research output: Contribution to journalArticle

231 Scopus citations